Re moderate/severe TBI trial, if I read correctly, they are doing the interim analysis at 80 (Cohort 1: 30 + Cohort 2: 30 + Cohort 3: 20), not 100?
They've got buckleys of acheiving 260 recruits by the March 2013 deadline.
Hopefully they can reduce the target of 260 to 200.
Tell the FDA it was a typo or something.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7585 | $12.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.03 | 3344 | 2 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |